Tag Archives: Rilpivirine

Tibotec licenses Rilpivirine (non exclusive) to Matrix, Hetero and Aspen

[J&J Press release] [Yahoo Finance] [Mylan Press Release] Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , | Leave a comment